Publicatie

Publication date

Varicella zoster virus (VZV) infection.

Lier, E.A. van, Suijkerbuijk, A.W.M., Nielen, M., Jochemsen, P., Luytjes, W., Melker, H.E. de. Varicella zoster virus (VZV) infection. In: Schurink-van 't Klooster, T.M., Melker, H.E. de (Eds). The National Immunisation Programme in the Netherlands: surveillance and developments in 2016-2017. Bilthoven: RIVM, 2017. p. 186-196.
Read online
• The VZV epidemiology (incidence of GP consultations, hospitalisations and deaths) is comparable to previous years.
• For the prevention of herpes zoster (HZ), HZ/su (or Shingrix®) might be a promising alternative for Zostavax® due to the higher sustained vaccine efficacy. It is now being submitted for regulatory approval in the USA, Canada, Japan and Europe.